← FDA DRUG APPROVALS

FDA NDA · NDA006620

CAFERGOT

Sponsor: NOVARTIS

APPLICATION
NDA006620
TYPE
NDA
ORIGINAL APPROVAL
1948-11-26
LATEST ACTION
1995-10-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CAFERGOTDiscontinued
CAFFEINE 100MG, ERGOTAMINE TARTRATE 1MG · TABLET · ORAL

Approval history

1995-10-12Manufacturing (CMC) · Supplement 53AP
1994-04-29Manufacturing (CMC) · Supplement 51AP
1994-04-15Manufacturing (CMC) · Supplement 49AP
1994-03-04Manufacturing (CMC) · Supplement 43AP
1994-02-28Manufacturing (CMC) · Supplement 42AP
1993-06-16Manufacturing (CMC) · Supplement 45AP
1993-04-15Manufacturing (CMC) · Supplement 46AP
1990-01-16Manufacturing (CMC) · Supplement 38AP
1989-11-07Manufacturing (CMC) · Supplement 40AP
1989-02-10Manufacturing (CMC) · Supplement 39AP
1988-11-17Manufacturing (CMC) · Supplement 37AP
1988-11-15Manufacturing (CMC) · Supplement 36AP
1985-11-19Manufacturing (CMC) · Supplement 30AP
1985-11-19Manufacturing (CMC) · Supplement 33AP
1985-03-26Manufacturing (CMC) · Supplement 32AP
1985-02-07Manufacturing (CMC) · Supplement 31AP
1982-03-29Manufacturing (CMC) · Supplement 27AP
1981-08-10Manufacturing (CMC) · Supplement 24AP
1981-08-10Manufacturing (CMC) · Supplement 25AP
1981-07-30Manufacturing (CMC) · Supplement 26AP
1981-01-29Manufacturing (CMC) · Supplement 23AP
1980-12-18Manufacturing (CMC) · Supplement 22AP
1979-11-06Manufacturing (CMC) · Supplement 20AP
1979-05-31Manufacturing (CMC) · Supplement 19AP
1979-05-30Manufacturing (CMC) · Supplement 17AP
1978-03-14Manufacturing (CMC) · Supplement 15AP
1977-08-31Manufacturing (CMC) · Supplement 14AP
1976-07-30Manufacturing (CMC) · Supplement 12AP
1976-05-06Manufacturing (CMC) · Supplement 11AP
1976-01-21Manufacturing (CMC) · Supplement 9AP
1975-08-12Manufacturing (CMC) · Supplement 8AP
1975-01-09Labeling · Supplement 6AP
1975-01-09Manufacturing (CMC) · Supplement 7AP
1948-11-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →